WOL 3D India (WOL3D)

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 82.48% shows strong demand momentum.
• ROCE of 30.11% indicates efficient capital deployment.
• P/E of 13.12 with PEG of 0.23 offers an attractive valuation relative to growth.
• Promoter holding of 64.73% keeps ownership aligned with minority investors.
• Piotroski F-Score of 7/9 points to solid overall financial health.

Concerns

• Profit growth of 30.72% trails sales growth of 82.48%, implying margin pressure.
• Book value, ROE and debt/equity are unavailable, limiting balance-sheet analysis.
• Micro-cap market cap of ₹85 Cr can lead to volatility and liquidity issues.
• No dividend means returns depend fully on future reinvestment success.

AI Analysis

At ₹166, WOL 3D India is a small-cap industrial products company with a market cap of just ₹85 Cr. Let me start with what attracts me: sales grew 82.48% and ROCE is 30.11%. That kind of return on capital, without using excessive leverage — though debt/equity is not disclosed — hints at a business with some competitive strength or asset-light efficiency. The Piotroski F-Score of 7/9 supports the view that fundamentals are sound. Promoters hold 64.73%, so their interests are largely aligned with mine as a minority shareholder. At 13.12 times earnings, the market is not asking me to pay a fancy premium for this growth; PEG at 0.23 suggests the Street has not yet fully recognised the trajectory. But I am a value investor, not a momentum trader. Profit growth at 30.72% is less than half the sales growth, and the latest quarter shows net profit of only ₹4 Cr on sales of ₹41 Cr — a margin of roughly 10%. This tells me that while demand is booming, competitive pressure or rising costs are squeezing profitability. Also, with no book value, no ROE, and no debt/equity disclosed, I cannot calculate a margin of safety the way Graham would demand. I never rely solely on reported earnings if I cannot inspect the balance sheet. Another concern: no dividend; I expect management to reinvest only while returns remain high. If ROCE sustains and growth continues, this could become a wonderful compounder. But the missing data means I need much more information before making a large commitment. I would watch whether profit growth catches up with sales growth and whether the balance sheet stays clean as the company scales.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer